
Clinical Application for Screening Down’s Syndrome by Using Carboxylated Graphene Oxide-Based Surface Plasmon Resonance Aptasensors
Author(s) -
Nan Fu Chiu,
Ying Hao Wang,
Chen-Yu Chen
Publication year - 2020
Publication title -
international journal of nanomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.245
H-Index - 128
eISSN - 1178-2013
pISSN - 1176-9114
DOI - 10.2147/ijn.s270938
Subject(s) - surface plasmon resonance , detection limit , graphene , biosensor , protein detection , oxide , nanotechnology , materials science , fetal bovine serum , selectivity , chemistry , chromatography , nanoparticle , biochemistry , in vitro , metallurgy , catalysis
Advanced medical detection technology requires high sensitivity and accuracy to increase the disease detection rate. We showed that carboxyl-functionalized graphene oxide (carboxyl-GO) biosensing materials are capable of accurate detection.